BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38083740)

  • 1. Brain Connectome Imaging Markers Research of Glucose Metabolism in the Early Stage of Alzheimer's Disease.
    Zhang Q; Wang L; Han Y; Jiang J; Wang M
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different glucose metabolic brain networks between Subjective Cognitive Decline and Health Control based on graph theory.
    Dong Q; Han Y; Jiang J
    Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():1084-1087. PubMed ID: 33018174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population.
    Dong QY; Li TR; Jiang XY; Wang XN; Han Y; Jiang JH
    Alzheimers Res Ther; 2021 Apr; 13(1):74. PubMed ID: 33827675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A metabolism-functional connectome sparse coupling method to reveal imaging markers for Alzheimer's disease based on simultaneous PET/MRI scans.
    Wang L; Xu H; Wang M; Brendel M; Rominger A; Shi K; Han Y; Jiang J
    Hum Brain Mapp; 2023 Dec; 44(17):6020-6030. PubMed ID: 37740923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different brain functional networks between subjective cognitive decline and health control based on graph theory.
    Li Z; Han Y; Jiang J
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():5752-5755. PubMed ID: 34892426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer's dementia.
    Wang M; Jiang J; Yan Z; Alberts I; Ge J; Zhang H; Zuo C; Yu J; Rominger A; Shi K;
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2753-2764. PubMed ID: 32318784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Alzheimer structural connectome: changes in cortical network topology with increased amyloid plaque burden.
    Prescott JW; Guidon A; Doraiswamy PM; Roy Choudhury K; Liu C; Petrella JR;
    Radiology; 2014 Oct; 273(1):175-84. PubMed ID: 24865310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease.
    Drzezga A; Altomare D; Festari C; Arbizu J; Orini S; Herholz K; Nestor P; Agosta F; Bouwman F; Nobili F; Walker Z; Frisoni GB; Boccardi M;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1487-1496. PubMed ID: 29756163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graph Analysis of Functional Brain Topology Using Minimum Spanning Tree in Subjective Cognitive Decline.
    Ren S; Hu J; Huang L; Li J; Jiang D; Hua F; Guan Y; Guo Q; Xie F; Huang Q
    J Alzheimers Dis; 2022; 90(4):1749-1759. PubMed ID: 36336928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermetabolic Cerebellar Connectome in Alzheimer's Disease.
    Gupta V; Booth S; Ko JH
    Brain Connect; 2023 Aug; 13(6):356-366. PubMed ID: 34155909
    [No Abstract]   [Full Text] [Related]  

  • 14. Rich club disturbances of the human connectome from subjective cognitive decline to Alzheimer's disease.
    Yan T; Wang W; Yang L; Chen K; Chen R; Han Y
    Theranostics; 2018; 8(12):3237-3255. PubMed ID: 29930726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Functional Brain Networks Between Subjective Cognitive Decline with and without Worry Groups: A Graph Theory Study from SILCODE.
    Liu Y; Li Z; Jiang X; Du W; Wang X; Sheng C; Jiang J; Han Y
    J Alzheimers Dis; 2021; 84(3):1279-1289. PubMed ID: 34657889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic interaction is associated with lower metabolic connectivity and memory impairment in clinically mild Alzheimer's disease.
    Chang YT; Huang CW; Huang SH; Hsu SW; Chang WN; Lee JJ; Chang CC
    Genes Brain Behav; 2019 Jun; 18(5):e12490. PubMed ID: 29883038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning based on the multimodal connectome can predict the preclinical stage of Alzheimer's disease: a preliminary study.
    Chen H; Li W; Sheng X; Ye Q; Zhao H; Xu Y; Bai F;
    Eur Radiol; 2022 Jan; 32(1):448-459. PubMed ID: 34109489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Network Properties Across Preclinical Stages of Alzheimer's Disease Using a Visual Short-Term Memory and Attention Task with High-Density Electroencephalography: A Brain-Connectome Neurophysiological Study.
    Lazarou I; Georgiadis K; Nikolopoulos S; Oikonomou VP; Stavropoulos TG; Tsolaki A; Kompatsiaris I; Tsolaki M;
    J Alzheimers Dis; 2022; 87(2):643-664. PubMed ID: 35367964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.